Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 20377 |
|---|---|
| 2: Name of authorisation holder | ALMAC CLINICAL SERVICES LIMITED |
| 3: Address(es) of manufacturing site(s) |
ALMAC CLINICAL SERVICES LIMITED, SEAGOE INDUSTRIAL ESTATE, 9 CHARLESTOWN ROAD, CRAIGAVON, NORTHERN IRELAND, BT63 5PW, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | ALMAC CLINICAL SERVICES LIMITED, SEAGOE INDUSTRIAL ESTATE, 9 CHARLESTOWN ROAD, CRAIGAVON, NORTHERN IRELAND, BT63 5PW, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 17/04/2024 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
ALMAC CLINICAL SERVICES LIMITED, SEAGOE INDUSTRIAL ESTATE, 9 CHARLESTOWN ROAD, CRAIGAVON, NORTHERN IRELAND, BT63 5PW, UNITED KINGDOM
Human Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Products |
| [ 1.1.3 ] Batch certification |
| [ 1.2 ] Non-sterile products |
| [ 1.2.2 ] Batch certification |
| [ 1.3 ] Biological medicinal products |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.1 ] Blood products |
| [ 1.3.2.2 ] Immunological products |
| [ 1.3.2.3 ] Cell therapy products |
| [ 1.3.2.4 ] Gene therapy products |
| [ 1.3.2.5 ] Biotechnology products |
| [ 1.3.2.6 ] Human or animal extracted products |